Report Highlights
What is Rheumatic disorders?
Rheumatic disorders are associated with joints tendons, ligaments, bones, and muscles. They are also called as musculoskeletal diseases. The field that studies these types of disorders is called rheumatology. At present, there are more than 200 distinct rheumatic diseases. Among which most common are osteoarthritis, rheumatoid arthritis (RA), lupus, Sjogren's syndrome, gout, scleroderma, infectious arthritis, and juvenile idiopathic arthritis.
Global Rheumatic Disorders Drug Market Outlook
Rheumatic disorders are recognized among the oldest decease. The economic and social burden of these diseases is huge, without improper approaches to management and control of these diseases, the impact is expected to increase as the population grows. The increasing aging population and smoking population and certain occupations which lead to injury and overuse of joints are increasing the prevalence of rheumatic disorders. The Centres for Disease Control and Prevention announced data estimating that 54.4 million U.S. adults suffer from arthritis - equating to about 25% of the population. Ongoing research on new biologic therapies is anticipated to spur the growth by 2026. Lack of arthritis awareness in a rural region and alternative therapies is seen to have a negative influence on the growth of the market.
Global Rheumatic Disorders Drug Market Competitive Landscape
The “Global Rheumatic Disorders Drug Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, Roche, Eli Lilly, ChemoCentryx and Corbus Pharmaceuticals. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More